Taylor Kurtz, Author at MMTC

Articles by Turner Davis, RPh

Turner Davis, RPh is a licensed pharmacist with over 25 years of experience in diverse pharmacy practice settings, including compounding, retail, home infusion, and long-term care. He is currently Managing Partner at Medical Marijuana Treatment Clinics of Florida, a leading network of clinics providing medical cannabis evaluations across the state. Turner has overseen operations at 25 clinic locations and served as the primary speaker at over 75 patient education events. His deep knowledge of Florida’s medical marijuana regulations, product development background with Surterra Wellness, and collaborative work with state agencies during rulemaking have positioned him as a trusted authority on medical cannabis. Turner is passionate about patient-centered care and empowering both patients and professionals through education on the therapeutic benefits and responsible use of medical marijuana.

Schedule Appointment

BREAKING NEWS: Supreme Court Rules Federal Gun Ban for Marijuana Users Unconstitutional—What Florida Medical Cannabis Patients Need to Know

June 20, 2026

For years, medical marijuana patients in Florida and across the country have faced a painful and unfair choice: protect their health using a state-legal natural medicine, or exercise their constitutional right to bear arms under the Second Amendment. On June 18, 2026, the United States Supreme Court dramatically shifted that landscape. In a historic, unanimous […]

Flying with Medical Cannabis: Navigating the TSA’s 2026 Policy Update

May 20, 2026

*Disclaimer: TSA has not yet published their “special instructions” to provide clear directions on traveling with medical marijuana. For years, one of the most stressful dilemmas for Florida medical marijuana patients has been travel. Packing for a flight meant deciding between leaving your essential medicine behind or risking a federal confrontation at airport security. Historically, […]

florida medical cannabis patient rolling joint

FDA Grants “Breakthrough Therapy” Status to Cannabis-Derived Pain Treatment

May 20, 2026

For decades, the standard pushback against medical cannabis from traditional medical institutions has been a demand for “more clinical proof.” Skeptics frequently argued that cannabis lacked the standardized, rigorous testing required of mainstream pharmaceuticals. That argument officially ended this week. In a historic milestone for cannabinoid medicine, the U.S. Food and Drug Administration (FDA) has […]